iShares Healthcare Innovation UCITS ETF (LON:HEAL)

Assets	1.23B
Expense Ratio	0.40%
PE Ratio	29.69
Forward PE	20.85
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	76,056
Open	11.42
Previous Close	11.38
Day's Range	11.38 - 11.45
52-Week Low	8.32
52-Week High	11.76
Beta	0.75
Holdings	286
Inception Date	Sep 8, 2016

About HEAL

iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe. The fund invests in stocks of companies operating in the healthcare innovation sector. It invests in stocks of small-cap, mid-cap and large-cap companies. The fund seeks to track the performance of the iSTOXX FactSet Breakthrough Healthcare Index, by employing representative sampling methodology. iShares Healthcare Innovation UCITS ETF was formed on September 8, 2016 and is domiciled in Ireland.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HEAL
• Provider: iShares
• Index Tracked: iSTOXX FactSet Breakthrough Healthcare

Performance

HEAL had a total return of 34.99% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.64%.

Top 10 Holdings

21.68% of assets

Name	Symbol	Weight
Moderna, Inc.	MRNA	6.25%
Genmab A/S	GMAB	2.48%
IQVIA Holdings Inc.	IQV	1.71%
Revvity, Inc.	RVTY	1.69%
Natera, Inc.	NTRA	1.64%
Celltrion, Inc.	068270	1.63%
Charles River Laboratories International, Inc.	CRL	1.59%
Roivant Sciences Ltd.	ROIV	1.57%
Amgen Inc.	AMGN	1.57%
Illumina, Inc.	ILMN	1.56%

Data Sources: S&P Global Market Intelligence, Financial Modeling Prep, and more

Historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep. Several fund data points are also provided by Finnhub.

Last checked:

Nov 11, 2026

Data Sources Report a data error